Abstract
Subcutaneous allergen immunotherapy (SCIT) is an effective treatment for allergic rhinitis, asthma, and venom hypersensitivity. Although rare, severe, and potentially life-threatening systemic reactions (SR) such as anaphylaxis can occur. However, our knowledge of SR between SCIT buildup (standard and accelerated) is limited. This study aimed to compare SCIT-related reactions between standard buildup (18-shot or 30-shot) and accelerated buildup (cluster).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
